Kenta Anjo

1PUBLICATIONS
16CO-AUTHORS
Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Oct 11, 2023
Phase II Trial of Nivolumab in Metastatic Rare Cancer with dMMR or MSI-H and Relation with Immune Phenotypic Analysis (the ROCK Trial).

Hitomi S Okuma, Keisuke Watanabe, Kenji Tsuchihashi

Pageof 1

Frequent Collaborators

1 joint publications

Hitomi S Okuma

1 joint publications

Keisuke Watanabe

1 joint publications

Kenji Tsuchihashi

1 joint publications

Ryunosuke Machida